Open-label, long-term extension study to evaluate the safety of clascoterone (CB-03-01) cream, 1% BID in patients with acne vulgaris
Journal of the American Academy of Dermatology | Apr 29, 2020
Most read this week
Journal of the American Academy of Dermatology | Apr 29, 2020